Search clinical trials for: NKTR-255 Q21
Total 3681 results
-
Nektar TherapeuticsCompletedMultiple Myeloma | Non-Hodgkin Lymphoma | Indolent Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterNektar TherapeuticsRecruitingLung CancerUnited States
-
U.S. Army Medical Research and Development CommandUniformed Services University of the Health Sciences; Meiji Seika Pharma Co...No longer availableInfection Due to Resistant OrganismUnited States
-
Nektar TherapeuticsRecruitingNon-Hodgkin Lymphoma | Relapsed/Refractory Diffuse Large B-cell LymphomaUnited States
-
Nektar TherapeuticsCompletedCervical Cancer | Colorectal Cancer | Head and Neck Squamous Cell Carcinoma | Anal Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Nektar TherapeuticsCompletedOvarian Cancer | TumorUnited States, Belgium, United Kingdom
-
United BioPharmaNational Taiwan University Hospital; Kaohsiung Medical University Chung-Ho... and other collaboratorsCompleted
-
UBP Greater China (Shanghai) Co., LtdNot yet recruiting
-
AbelZeta, Inc.Nektar TherapeuticsRecruiting
-
Nektar TherapeuticsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Nektar TherapeuticsCompletedLow Back Pain | Chronic PainUnited States
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Calithera Biosciences, IncNektar TherapeuticsWithdrawnLymphoma, Non-HodgkinUnited States, Canada
-
Nektar TherapeuticsCompletedMalignant Solid TumorUnited States, Belgium
-
Nektar TherapeuticsCompletedLow Back Pain | Chronic PainUnited States
-
Nektar TherapeuticsCompletedAdvanced or Metastatic Solid Tumors in Patients With Hepatic ImpairmentUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany
-
Nektar TherapeuticsCompletedCovid-19 | Coronavirus Disease 2019United States
-
Sichuan Haisco Pharmaceutical Group Co., LtdCompletedDiabetes Mellitus, Type 2China
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Nektar TherapeuticsEli Lilly and CompanyCompletedSystemic Lupus ErythematosusUnited States
-
Nykode Therapeutics ASANektar Therapeutics; Vaccibody ASCompletedLocally Advanced or Metastatic Solid TumoursGermany
-
Nektar TherapeuticsEli Lilly and CompanyTerminatedColitis, UlcerativeAustralia, India, United States, Korea, Republic of, Hungary, United Kingdom, Japan, Argentina, Belgium, Brazil, Canada, China, Czechia, France, Georgia, Israel, Latvia, Poland, Romania, Russian Federation, Slovakia, Ukraine
-
Università Politecnica delle MarcheUnknownInfant, Very Low Birth WeightItaly
-
Nektar TherapeuticsCompletedOsteoarthritis of the KneeUnited States
-
TakedaTakeda Development Center Americas, Inc.RecruitingThrombotic Thrombocytopenic Purpura (TTP)United States, Spain, Italy, Greece, United Kingdom, Argentina, Poland, Austria
-
TakedaShire; Takeda Development Center Americas, Inc.RecruitingThrombotic Thrombocytopenic Purpura (TTP)China, United States, France, Japan, Poland, Germany, Austria, Spain, Italy, Switzerland, United Kingdom
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisUnited States, Canada
-
Nektar TherapeuticsRecruiting
-
Nektar TherapeuticsEli Lilly and CompanyCompletedSystemic Lupus ErythematosusUnited States, Spain, Japan, India, Israel, Korea, Republic of, Taiwan, Australia, Puerto Rico, Argentina, Romania, Canada, Germany, Russian Federation, Mexico, Ukraine, Poland, Czechia, Hungary
-
Memorial Sloan Kettering Cancer CenterRecruitingNeuroblastoma | High-risk Neuroblastoma | Metastatic NeuroblastomaUnited States
-
MedImmune LLCCompletedAsthmaUnited States, Czech Republic, France, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, United Kingdom, Germany, Philippines, Argentina, Canada, Chile, Japan
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.RecruitingThrombotic Thrombocytopenic Purpura (TTP)United States, Spain, Poland, Italy, Germany, France, Switzerland, Austria, Japan, United Kingdom
-
Vicore Pharma ABSGS Life Sciences, a division of SGS Belgium NVCompleted
-
Nektar TherapeuticsCompletedColorectal Cancer | TumorUnited States
-
Chinese PLA General HospitalTsinghua UniversityUnknownGlioma | Breast Cancer | Pancreatic Cancer | Prostate Cancer | Colon Cancer | Hepatocellular Cancer | Squamous Cell Lung CancerChina
-
Peking University Cancer Hospital & InstituteUnknown
-
Centre Hospitalier Universitaire de NiceCompletedUnrecognized Condition
-
Alkahest, Inc.CompletedEnd-Stage Renal DiseaseUnited States
-
Université de MontréalInstitut de Recherche Robert-Sauvé en Santé et en Sécurité du TravailUnknown
-
Eisai Inc.Completed
-
Fred Hutchinson Cancer CenterNektar TherapeuticsRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Recurrent Grade 3b Follicular Lymphoma | Refractory Grade 3b Follicular... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNeuroblastomaUnited States
-
Abbott Medical DevicesAbbottCompletedMitral Regurgitation | Mitral Valve RegurgitationNetherlands, United Kingdom, United States, Spain, Israel, Germany, Italy, Switzerland
-
Nektar TherapeuticsBristol-Myers SquibbCompletedMelanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Urothelial Carcinoma | HR+/HER2- Breast CancerUnited States, Spain, Canada, France, Italy, Belgium, Poland, United Kingdom
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Stanford University; Rockefeller UniversityActive, not recruiting
-
Imperial College LondonAstraZeneca; Medical Research Council; National Institute for Health Research...CompletedMenopausal FlushingUnited Kingdom